CIK: 1438421 - Address: C/O Gritstone Bio, Inc., 5959 Horton Street, Suite 300, Emeryville, CA 94608
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113051-12-16251
S%wins330505050031

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/4/22 18:20
8/2/22
NBRVNabriva Therapeutics PlcL2HealthDrugPharmaceutical PreparationsWebster Stephen WPADS-10.19000-8-4111D
8/4/21 21:08
8/2/21
NBRVNabriva Therapeutics PlcL2HealthDrugPharmaceutical PreparationsWebster Stephen WPADS-11.200-1-419D
11/20/17 17:14
11/16/17
ONCESpark Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagWebster Stephen WPAOCFOS.d-70170.140-10-803D
8/15/17 17:05
8/15/17
ONCESpark Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagWebster Stephen WPAOCFOS.d-79479.380-10-803D
8/2/17 17:58
7/31/17
ONCESpark Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagWebster Stephen WPAOCFOS.d-16671.120-2-483D
6/21/17 16:43
6/19/17
ONCESpark Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagWebster Stephen WPAOCFOS.d-46060.000-8-753D
4/26/17 17:48
4/24/17
ONCESpark Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagWebster Stephen WPAOCFOS.dm-55255.1810-10-803D-7479-3-3109513
5/24/16 17:06
5/20/16
ONCESpark Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagWebster Stephen WPAOCFOS.d-1,00850.3918-20-893D-191696454603235-1294
10/9/15 19:20
10/7/15
ONCESpark Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagWebster Stephen WPAOCFOS.d-97748.8633-20-893D-34-227122-11-4714-32-3625

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact